1
Return

Progress, pitfalls and promise: the journey to effective and well tolerated DNA damage response inhibitor combinations in the clinic

delete2024-12-09
delete0
PRE
AI
T
Timothy A. Yap
DOI:10.1158/1538-8514.CANCERCHEM24-IA006delete
deleteOriginal
deleteOriginal request for help
deleteShare
deleteSave
Abstract

Abstract

En

Journal

Molecular Cancer Therapeutics cover
Molecular Cancer Therapeutics
IF:
5.5
Papers:
9.0K
Citations:
2.0W

Organization

No organization information available
Cited Papers

Cited Papers

Citing Papers

Citing Papers